The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
27 10 2023
Historique:
received: 17 05 2023
accepted: 06 10 2023
medline: 30 10 2023
pubmed: 28 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

A positron emission tomography (PET) tracer detecting α-synuclein pathology will improve the diagnosis, and ultimately the treatment of α-synuclein-related diseases. Here we show that the PET ligand, [

Identifiants

pubmed: 37891183
doi: 10.1038/s41467-023-42305-3
pii: 10.1038/s41467-023-42305-3
pmc: PMC10611796
doi:

Substances chimiques

alpha-Synuclein 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

6750

Subventions

Organisme : NIA NIH HHS
ID : P30 AG019610
Pays : United States
Organisme : NINDS NIH HHS
ID : U24 NS072026
Pays : United States

Informations de copyright

© 2023. Springer Nature Limited.

Références

JAMA. 2018 Sep 18;320(11):1151-1162
pubmed: 30326496
JAMA Neurol. 2020 Nov 1;77(11):1408-1419
pubmed: 33165511
Neurology. 2008 Aug 26;71(9):670-6
pubmed: 18725592
Arch Neurol. 1999 Jan;56(1):33-9
pubmed: 9923759
Brain. 2010 Jan;133(Pt 1):172-88
pubmed: 19903734
Mov Disord. 2022 Oct;37(10):2159-2161
pubmed: 36041211
Neuropathol Appl Neurobiol. 2017 Jun;43(4):315-329
pubmed: 27716988
Ann Neurol. 2015 Nov;78(5):787-800
pubmed: 26344059
Int Rev Neurobiol. 2019;149:137-192
pubmed: 31779811
N Engl J Med. 2023 Jan 5;388(1):9-21
pubmed: 36449413
Brain. 2018 Jul 1;141(7):2181-2193
pubmed: 29878075
J Neurochem. 2016 Jan;136(1):172-85
pubmed: 26465922
Nature. 2020 Feb;578(7794):273-277
pubmed: 32025029
Neurol Genet. 2017 Aug 24;3(5):e183
pubmed: 28852709
Front Neurosci. 2022 Feb 08;16:807435
pubmed: 35210989
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
Mov Disord. 2017 Jun;32(6):853-864
pubmed: 28467028
Nat Med. 2021 Jun;27(6):954-963
pubmed: 34083813
Brain. 2019 Sep 1;142(9):2813-2827
pubmed: 31289815
Arch Neurol. 2004 Dec;61(12):1915-9
pubmed: 15596612
Mov Disord. 2005 Aug;20 Suppl 12:S29-36
pubmed: 16092088
Parkinsonism Relat Disord. 2016 Jan;22 Suppl 1:S1-6
pubmed: 26350119
Ann Neurol. 2020 Sep;88(3):503-512
pubmed: 32557811
JAMA Neurol. 2015 Jul;72(7):789-96
pubmed: 25985321
Nat Rev Neurol. 2013 Jan;9(1):13-24
pubmed: 23183883
Parkinsonism Relat Disord. 2009 Jun;15(5):390-2
pubmed: 18824390
JAMA Neurol. 2020 Aug 1;77(8):955-965
pubmed: 32391858
Nature. 2020 Sep;585(7825):464-469
pubmed: 32461689
Parkinsonism Relat Disord. 2014 Aug;20(8):919-23
pubmed: 24816001
J Nucl Med. 2022 Oct;63(10):1551-1559
pubmed: 35086898

Auteurs

Ruben Smith (R)

Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Department of Neurology, Skåne University Hospital, Lund, Sweden.

Francesca Capotosti (F)

AC Immune SA, EPFL Innovation Park, Building B, 1015, Lausanne, Switzerland.

Martin Schain (M)

Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Antaros Medical, Mölndal, Sweden.
Neurobiology Research Unit, Copenhagen University Hospital, Copenhagen, Denmark.

Tomas Ohlsson (T)

Department of Radiation Physics, Skånes University Hospital, Lund, Sweden.

Efthymia Vokali (E)

AC Immune SA, EPFL Innovation Park, Building B, 1015, Lausanne, Switzerland.

Jerome Molette (J)

AC Immune SA, EPFL Innovation Park, Building B, 1015, Lausanne, Switzerland.

Tanja Touilloux (T)

AC Immune SA, EPFL Innovation Park, Building B, 1015, Lausanne, Switzerland.

Valerie Hliva (V)

AC Immune SA, EPFL Innovation Park, Building B, 1015, Lausanne, Switzerland.

Ioannis K Dimitrakopoulos (IK)

AC Immune SA, EPFL Innovation Park, Building B, 1015, Lausanne, Switzerland.

Andreas Puschmann (A)

Department of Neurology, Skåne University Hospital, Lund, Sweden.
Neurology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
SciLifeLab National Research Infrastructure, Lund University, Lund, Sweden.

Jonas Jögi (J)

Department of Clinical Physiology and Nuclear Medicine, Skåne University Hospital, Lund, Sweden.

Per Svenningsson (P)

Department of Neurology, Academic Specialist Center, Karolinska University Hospital, Stockholm, Sweden.

Mattias Andréasson (M)

Department of Neurology, Academic Specialist Center, Karolinska University Hospital, Stockholm, Sweden.

Christine Sandiego (C)

Invicro, LLC, New Haven, CT, USA.

David S Russell (DS)

Invicro, LLC, New Haven, CT, USA.

Patricia Miranda-Azpiazu (P)

Clinical Neuroscience, PET Division, Karolinska Institute, Stockholm, Sweden.

Christer Halldin (C)

Clinical Neuroscience, PET Division, Karolinska Institute, Stockholm, Sweden.

Erik Stomrud (E)

Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Memory Clinic, Skåne University Hospital, Lund, Sweden.

Sara Hall (S)

Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden.
Memory Clinic, Skåne University Hospital, Lund, Sweden.

Klas Bratteby (K)

Department of Radiation Physics, Skånes University Hospital, Lund, Sweden.

Elina Tampio L'Estrade (E)

Department of Radiation Physics, Skånes University Hospital, Lund, Sweden.

Ruth Luthi-Carter (R)

AC Immune SA, EPFL Innovation Park, Building B, 1015, Lausanne, Switzerland.

Andrea Pfeifer (A)

AC Immune SA, EPFL Innovation Park, Building B, 1015, Lausanne, Switzerland.

Marie Kosco-Vilbois (M)

AC Immune SA, EPFL Innovation Park, Building B, 1015, Lausanne, Switzerland.

Johannes Streffer (J)

AC Immune SA, EPFL Innovation Park, Building B, 1015, Lausanne, Switzerland. johannes.streffer@uantwerpen.be.
Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium. johannes.streffer@uantwerpen.be.

Oskar Hansson (O)

Clinical Memory Research Unit, Department of Clinical Sciences, Malmö, Lund University, Lund, Sweden. Oskar.Hansson@med.lu.se.
Memory Clinic, Skåne University Hospital, Lund, Sweden. Oskar.Hansson@med.lu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH